+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Insulin Pumps Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805786
The global insulin pump market attained a value of nearly USD 4.7 billion in 2022, driven by the ageing population, unhealthy lifestyle habits, and increasing obesity rates. The market is likely to grow at a CAGR of 6.2% during the forecast period of 2023-2031 to attain a value of USD 8.1 billion by 2031.

Insulin Pump Market: Introduction

An insulin pump is a small, computerized device that delivers insulin into the body. It's primarily used by people with type 1 diabetes but can also be beneficial for some people with type 2 diabetes. The device is about the size of a small cell phone and is usually worn externally, on a belt or in a pocket. The insulin pump is connected to the body through a thin plastic tube, known as an infusion, set, with a cannula at the end that is inserted under the skin, usually in the abdomen.

The insulin pump works by delivering a steady, continuous dose of short-acting insulin (known as basal rate) throughout the day and night, which mimics the natural, continuous release of insulin by a healthy pancreas. It also allows the user to deliver a larger dose of insulin (a bolus dose) at mealtimes or when a correction is needed due to high blood glucose levels.

Uses of Insulin Pumps:
Insulin pumps are used to manage blood glucose levels in individuals with diabetes. It is also used for the following purposes:
  • Deliver a steady, continuous supply of insulin (basal insulin) to keep blood sugar levels stable between meals and overnight
  • Allow the user to manually administer extra doses of insulin (bolus insulin) at mealtimes, or when blood sugar levels are higher than desired
  • Can be programmed to deliver varying amounts of insulin at different times of the day, which can be beneficial for individuals with varying insulin needs
Benefits of Insulin Pumps:
Insulin pumps can offer several benefits over traditional insulin injections:
  • Improved Blood Sugar Control: The continuous delivery of insulin can help to maintain more stable blood sugar levels, reducing the risk of both high (hyperglycaemia) and low (hypoglycaemia) blood sugar episodes
  • Increased Flexibility: An insulin pump can offer greater flexibility in terms of lifestyle, as users can adjust their insulin delivery to match changes in their schedule, activity levels, or food intake
  • Less Frequent Injections: Using an insulin pump means you only need to change the infusion set every two to three days, as opposed to multiple daily injections
  • Dose Precision: Insulin pumps can deliver very precise amounts of insulin, which can be particularly beneficial for children or individuals who require small doses of insulin
  • Improved Quality of Life: Many people find that insulin pumps improve their quality of life, as they offer more freedom and flexibility, and make diabetes management less intrusive
  • However, insulin pumps are not suitable for everyone, and using one requires training and regular follow-up with a healthcare team. It is important to discuss this treatment option with a healthcare provider to determine if it's the right choice for an individual's specific needs and lifestyle

Insulin Pump Market Segmentations

Market Breakup by Product Type

Insulin Pumps

  • Tethered Pumps
  • Disposable/Patch Insulin Pumps

Insulin Pump Supplies and Accessories

  • Insulin Reservoirs/Cartridges
  • Infusion Set Insertion Devices

Market Breakup by Disease Indication

  • Type I Diabetes
  • Type II Diabetes

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Insulin Pump Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Insulin Pump Market Scenario

As of my knowledge cut-off in September 2021, the global insulin pump market was witnessing steady growth, driven by increasing prevalence of diabetes, advancements in insulin pump technology, and rising awareness about the benefits of insulin pumps over traditional insulin injection methods.

The market was also being influenced by factors such as the ageing population, unhealthy lifestyle habits, and increasing obesity rates, which are all linked to a higher incidence of diabetes. Countries with higher rates of diabetes, such as the United States, India, and China, were significant contributors to the global insulin pump market.

In terms of technology, advancements were playing a crucial role in the growth of the insulin pump market. Manufacturers were focusing on developing smaller, more convenient, and more precise devices. For example, the development of 'artificial pancreas' systems, which combine insulin pumps with continuous glucose monitors to automatically adjust insulin delivery based on blood sugar levels, was a significant innovation.

Furthermore, wireless and smartphone-compatible insulin pumps were gaining traction, enabling users to control their insulin delivery using a smartphone app and improving their overall quality of life. This integration of digital health technology with insulin pumps was expected to drive future growth in the market.

However, the insulin pump market was also facing challenges. The high cost of insulin pumps and the ongoing need for consumable supplies can be prohibitive for many potential users. Additionally, some users find the need to wear a device continuously to be a significant drawback. Finally, potential technical issues and the risk of complications, such as infection at the infusion site, can also hinder market growth.

Key Players in the Global Insulin Pump Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Insulet Corporation
  • Medtronic
  • Roche
  • Tandem Diabetes Care, Inc
  • Ypsomed AG
  • Ascensia Diabetes Care
  • Apex Medical
  • Menarini Diagnostics s.r.l

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Insulin Pump Market Overview
3.1 Global Insulin Pump Market Historical Value (2016-2022)
3.2 Global Insulin Pump Market Forecast Value (2023-2031)
4 Global Insulin Pump Market Landscape
4.1 Global Insulin Pump Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Insulin Pump Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Disease Indication
4.2.3 Analysis by Distribution Channel
5 Global Insulin Pump Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Insulin Pump Market Segmentation
6.1 Global Insulin Pump Market by Product Type
6.1.1 Market Overview
6.1.2 Insulin Pumps Tethered Pumps Disposable/Patch Insulin Pumps
6.1.3 Insulin Pump Supplies and Accessories Insulin Reservoirs/Cartridges Infusion Set Insertion Devices
6.2 Global Insulin Pump Market by Disease Indication
6.2.1 Market Overview
6.2.2 Type I Diabetes
6.2.3 Type II Diabetes
6.3 Global Insulin Pump Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Pharmacy
6.4 Global Insulin Pump Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Insulin Pump Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Insulin Pump Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Insulin Pump Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Insulin Pump Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Insulin Pump Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Insulet Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Medtronic
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Roche
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Tandem Diabetes Care, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Ypsomed AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Ascensia Diabetes Care
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Apex Medical
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 A. Menarini Diagnostics s.r.l
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
18 Global Insulin Pump Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Insulet Corporation
  • Medtronic
  • Roche
  • Tandem Diabetes Care Inc.
  • Ypsomed AG
  • Ascensia Diabetes Care
  • Apex Medical
  • A. Menarini Diagnostics s.r.l



Table Information